FDA
-
-
-
-
-
-
-
BELLUS Health Inc (BLU) Reports Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937
-
-
-
-
-
-
-
BLU SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.
-
-
-
-
-
-
-
BLU SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.
-
-
-
-
-
-
-
Lowey Dannenberg, P.C. Announces Filing of Securities Class Action Lawsuit Against Bellus Health Inc. on Behalf of Investors Who Acquired Shares from September 19, 2019 to July 5, 2020 and Encourages
-
-
-
-
-
-
-
BELLUS Health Reports Third Quarter 2020 Financial Results and Business Highlights
-
-
-
-
-
-
322,245 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

